Merck Tbk Financials
| MERK Stock | IDR 3,580 10.00 0.28% |
Merck |
Merck Tbk Stock Summary
Merck Tbk competes with Mitra Keluarga, Siloam International, Sumber Alfaria, and Elang Mahkota. PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. Merck Tbk operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 405 people.| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000136609 |
| Business Address | Jl TB Simatupang |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.merckgroup.com/id-id |
| Phone | 62 21 2856 5600 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Merck Tbk without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Merck Stock, because this is throwing your money away. Analyzing the key information contained in Merck Tbk's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Merck Tbk Key Financial Ratios
Merck Tbk's financial ratios allow both analysts and investors to convert raw data from Merck Tbk's financial statements into concise, actionable information that can be used to evaluate the performance of Merck Tbk over time and compare it to other companies across industries.Merck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Merck Tbk's current stock value. Our valuation model uses many indicators to compare Merck Tbk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merck Tbk competition to find correlations between indicators driving Merck Tbk's intrinsic value. More Info.Merck Tbk is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.67 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merck Tbk is roughly 1.48 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merck Tbk's earnings, one of the primary drivers of an investment's value.Merck Tbk Systematic Risk
Merck Tbk's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Merck Tbk volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Merck Tbk correlated with the market. If Beta is less than 0 Merck Tbk generally moves in the opposite direction as compared to the market. If Merck Tbk Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Merck Tbk is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Merck Tbk is generally in the same direction as the market. If Beta > 1 Merck Tbk moves generally in the same direction as, but more than the movement of the benchmark.
Merck Tbk December 14, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Merck Tbk help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Merck Tbk. We use our internally-developed statistical techniques to arrive at the intrinsic value of Merck Tbk based on widely used predictive technical indicators. In general, we focus on analyzing Merck Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Merck Tbk's daily price indicators and compare them against related drivers.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 4.66 | |||
| Value At Risk | (1.16) | |||
| Potential Upside | 1.47 |
Other Information on Investing in Merck Stock
Merck Tbk financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck Tbk security.